| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
V.p., Clinical Affairs
1 company
Holdbrook Mark J. is a V.p., Clinical Affairs at TARS. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $40K at current prices.
Our model assigns Holdbrook Mark J. a below-average insider score of 9/100, based on 3 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -100.0%.
Holdbrook Mark J.'s largest disclosed position is in TARS as V.p., Clinical Affairs, worth about $40K. The recent filings there lean toward selling, a net 573 shares.